EEF1A1 and prostate carcinoma: To get more insight, we investigated the EEF1A1/A2 differential expression in a panel of prostate cancer cell lines: the androgen-responsive LNCaP and the non-responsive DU-145, PC-3 cells, described to display a low, moderate and high aggressive phenotype, respectively (Aalinkeel et al, 2004).